In contrast, activation of STING signaling in antigen-presenting cell types (e.g., macrophages and DCs) was found to be critical for inducing a tumor-specific adaptive immune response induced by irradiation therapy or STING agonist–adjuvanted cancer vaccine (25, 40). This evidence concerns the gene STING1 and neoplasm.